-
Tubastatin A盐酸盐是HDAC6选择性抑制剂，IC50为15 nM，比对其它亚型的抑制性高1000倍（相对HDAC8是57倍）。
More
-
Sodium phenylbutyrate (NaPB), a derivative of the short-chain fatty acid butyrate, is a low-potency histone deacetylase inhibitor and originally approved for treatment of UCD. Sodium Phenylbutyrate是一种转录调节因子，通过调控HDAC活性来改变染色质结构从而发挥作用,是组蛋白脱乙酰酶（HDAC）抑制剂，IC50为1-5 uM。
More
-
Pazopanib, an orally available multi-kinase inhibitor of VEGFR, PDGFR, KIT, FGFR, as well as RAF, shows potent activity against a variety of solid tumors. Pazopanib是多重靶点抑制剂，对VEGFR1， VEGFR2，VEGFR3，PDGFR，FGFR，c-Kit 和 c-Fms的IC50分别为10 nM，30 nM，47 nM，84 nM，74 nM，140 nM和146 nM。
More
-
PF-3758309, a potent ATP-competitive inhibitor of PAK1 and PAK4, displays broad anti-tumor activity in cellular proliferation and apoptosis. PF-3758309是PAK4抑制剂，IC50为1.3 nM，能抑制HCT116，A549，M24met和别的肿瘤外植体模型。
More
-
Doramapimod (BIRB 796)是高度选择性p38α MAPK抑制剂，Kd为0.1 nM，对JNK2，c-RAF，Fyn，Lck，ERK-1，SYK，IKK2，ZAP-70，EGFR，HER2，PKA，PKC和PKCα/β/γ的抑制性较弱。
More
